Relaxin induces matrix-metalloproteinases-9 and-13 via RXFP1: Induction of MMP-9 involves the PI3K, ERK, Akt and PKC-ζ pathways

被引:53
作者
Ahmad, Nisar [1 ]
Wang, Wei [1 ]
Nair, Remi [1 ]
Kapila, Sunil [1 ]
机构
[1] Univ Michigan, Ann Arbor, MI 48109 USA
关键词
Relaxin receptors; Synovial joint fibrochondrocytes; Matrix metalloproteinases; ERK; Akt; Transcription factors; FAMILY PEPTIDE RECEPTORS; NF-KAPPA-B; GENE-KNOCKOUT MOUSE; RAT PUBIC SYMPHYSIS; KINASE-C-ZETA; SIGNALING PATHWAYS; IN-VITRO; CYCLIC ADENOSINE-3'; 5'-MONOPHOSPHATE; MATRIX METALLOPROTEINASES; FIBROCARTILAGINOUS CELLS;
D O I
10.1016/j.mce.2012.07.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We determined the precise role of relaxin family peptide (RXFP) receptors-1 and -2 in the regulation of MMP-9 and -13 by relaxin, and delineated the signaling cascade that contributes to relaxin's modulation of MMP-9 in fibrocartilaginous cells. Relaxin treatment of cells in which RXFP1 was silenced resulted in diminished induction of MMP-9 and -13 by relaxin, whereas overexpression of RXFP1 potentiated the relaxin-induced expression of these proteinases. Suppression or overexpression of RXFP2 resulted in no changes in the relaxin-induced MMP-9 and -13. Studies using chemical inhibitors and siRNAs to signaling molecules showed that PI3K, Akt, ERK and PKC-zeta and the transcription factors EIk-1, c-fos and, to a lesser extent, NF-kappa B are involved in relaxin's induction of MMP-9. Our findings provide the first characterization of signaling cascade involved in the regulation of any MMP by relaxin and offer mechanistic insights on how relaxin likely mediates extracellular matrix turnover. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:46 / 61
页数:16
相关论文
共 82 条
  • [1] Relaxin: A pleiotropic hormone
    Bani, D
    [J]. GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1997, 28 (01): : 13 - 22
  • [2] Receptors for relaxin family peptides
    Bathgate, RA
    Ivell, R
    Sanborn, BM
    Sherwood, OD
    Summers, RJ
    [J]. RELAXIN AND RELATED PEPTIDES: FOURTH INTERNATIONAL CONFERENCE, 2005, 1041 : 61 - 76
  • [3] Relaxin: new peptides, receptors and novel actions
    Bathgate, RAD
    Samuel, CS
    Burazin, TCD
    Gundlach, AL
    Tregear, GW
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2003, 14 (05) : 207 - 213
  • [4] GREAT/LGR8 is the only receptor for insulin-like 3 peptide
    Bogatcheva, NV
    Truong, A
    Feng, S
    Engel, W
    Adham, IM
    Agoulnik, AI
    [J]. MOLECULAR ENDOCRINOLOGY, 2003, 17 (12) : 2639 - 2646
  • [5] A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways
    Byun, Hee-Jung
    Hong, In-Kee
    Kim, Eunsook
    Jin, Young-June
    Jeoung, Doo-Il
    Hahn, Jang-Hee
    Kim, Young-Myoung
    Park, Seong Hoe
    Lee, Hansoo
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (46) : 34833 - 34847
  • [6] Regulation of matrix metalloproteinases: An overview
    Chakraborti, S
    Mandal, M
    Das, S
    Mandal, A
    Chakraborti, T
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2003, 253 (1-2) : 269 - 285
  • [7] Analogs of insulin-like peptide 3 (INSL3) B-chain are LGR8 antagonists in vitro and in vivo
    Del Borgo, MP
    Hughes, RA
    Bathgate, RAD
    Lin, F
    Kawamura, K
    Wade, JD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (19) : 13068 - 13074
  • [8] Relaxin stimulates multiple signaling pathways -: Activation of cAMP, PI3K, and PKCξ in THP-1 cells
    Dessauer, CW
    Nguyen, BT
    [J]. RELAXIN AND RELATED PEPTIDES: FOURTH INTERNATIONAL CONFERENCE, 2005, 1041 : 272 - 279
  • [9] ZETA-PKC INDUCES PHOSPHORYLATION AND INACTIVATION OF I-KAPPA-B-ALPHA IN-VITRO
    DIAZMECO, MT
    DOMINGUEZ, I
    SANZ, L
    DENT, P
    LOZANO, J
    MUNICIO, MM
    BERRA, E
    HAY, RT
    STURGILL, TW
    MOSCAT, J
    [J]. EMBO JOURNAL, 1994, 13 (12) : 2842 - 2848
  • [10] THE PHYSIOLOGICAL-ROLE OF RELAXIN IN THE PREGNANT RAT .4. THE INFLUENCE OF RELAXIN ON CERVICAL COLLAGEN AND GLYCOSAMINOGLYCANS
    DOWNING, SJ
    SHERWOOD, OD
    [J]. ENDOCRINOLOGY, 1986, 118 (02) : 471 - 479